Steven A Burton, MD

  • Clinical Professor, Radiation Oncology

I’m a full-time clinician at UPMC Shadyside specializing in stereotactic radiosurgery, including tumors of the brain, lung, pancreas, and spine. My research interests include stereotactic radiotherapy for brain, spine, and lung tumors. I am involved in resident and medical student teaching.


Teaching Activities:

  • Residency Clinical Setting and Lectures: In 2018-2019 our 8 residents participated in over 2,000 hours of lectures, clinic precepting and supervision through our residency program office.
  • Medical Students and Fellows: In 2018-2019 I mentored approximately 15 medical students and/or fellows within the radiation oncology department at UPMC Shadyside.


Sutera PA, Bernard ME, Gill BS, Harper KK, Quan K, Bahary N, Burton SA, Zeh H, Heron DE. One vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective Review. Front Oncol. 2017 Nov 14;7:272.

Horne ZD, Richman AH, Dohopolski MJ, Clump DA, Burton SA, Heron DE. Stereotactic Body Radiation Therapy for isolated hilar and mediastinal non-small cell lung cancers. Lung Cancer. 2018 Jan; 115:1-4.

Sutera P, Bernard ME, Wang H, Bahary N, Burton S, Zeh H, Heron DE. Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation. Front Oncol. 2018 Mar 7;8:52.

Dohopolski MJ, Horne Z, Clump D, Burton SA, Heron DE. Stereotactic Body Radiation Therapy for Pulmonary Oligometastases Arising from Non-lung Primaries in Patients Without Extrapulmonary Disease. Cureus. 2018 Feb 7;10(2):e2167.

Horne ZD, Dohopolski MJ, Clump DA, Burton SA, Heron DE. Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field. Pract Radiat Oncol. 2018 May-Jun;8(3):e117-123.

Kalash R, Glaser SM, Flickinger JC, Burton S, Heron DE, Gerzten PC, Engh JA, Amankulor NM, Vargo JA. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate? J Neurosurg Spine. 2018 May 25:1-6.